top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Verastem, Inc. - Common Stock (NQ:VSTM)

7.780 -0.280 (-3.47%)

Streaming Delayed Price Updated: 2:41 PM EST, Dec 29, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	526,089
Open	7.970
Bid (Size)	7.780 (600)
Ask (Size)	7.800 (700)
Prev. Close	8.060
Today's Range	7.780 - 8.030
52wk Range	3.455 - 11.24
Shares Outstanding	44,784,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗

December 28, 2025

When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.

Via The Motley Fool

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗

December 28, 2025

ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.

Via The Motley Fool

Performance

YTD	+19.9%	+19.9%
1 Month	-26.9%	-26.9%
3 Month	-10.0%	-10.0%
6 Month	+87.5%	+87.5%
1 Year	+112.0%	+112.0%

More News

Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth

December 15, 2025

From Verastem Oncology

Via Business Wire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Verastem Stock Ignites Retail Buzz After Early Cancer Drug Data Show Tumor Reduction, Mild Side Effects ↗

October 24, 2025

Via Stocktwits

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference

November 25, 2025

From Verastem Oncology

Via Business Wire

Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants

November 14, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Proposed Public Offering of Common Stock

November 13, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at Upcoming Investor Conferences

November 05, 2025

From Verastem Oncology

Via Business Wire

Verastem Inc (NASDAQ:VSTM) Reports Q3 2025 Revenue Beat Amid Widened Loss ↗

November 04, 2025

Via Chartmill

Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

November 04, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors

October 23, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025

October 23, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma

October 19, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 07, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at Upcoming Investor Conferences

August 27, 2025

From Verastem Oncology

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 13, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

August 13, 2025

Via Chartmill

Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer

August 13, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

August 07, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

July 29, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Granted Fast Track Designation for VS-7375 for the Treatment of KRAS G12D-mutated Locally Advanced or Metastatic Pancreatic Cancer

July 24, 2025

From Verastem Oncology

Via Business Wire

Frequently Asked Questions

Is Verastem, Inc. - Common Stock publicly traded?

Yes, Verastem, Inc. - Common Stock is publicly traded.

What exchange does Verastem, Inc. - Common Stock trade on?

Verastem, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Verastem, Inc. - Common Stock?

The ticker symbol for Verastem, Inc. - Common Stock is VSTM on the Nasdaq Stock Market

What is the current price of Verastem, Inc. - Common Stock?

The current price of Verastem, Inc. - Common Stock is 7.780

When was Verastem, Inc. - Common Stock last traded?

The last trade of Verastem, Inc. - Common Stock was at 12/29/25 02:41 PM ET

What is the market capitalization of Verastem, Inc. - Common Stock?

The market capitalization of Verastem, Inc. - Common Stock is 348.42M

How many shares of Verastem, Inc. - Common Stock are outstanding?

Verastem, Inc. - Common Stock has 348M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bottom of page